EDMONTON, ALBERTA--(Marketwire - July 16, 2008) - ViRexx Medical Corp. (TSX: VIR) (AMEX: REX) a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumours, today announced that it has set a record date of July 25, 2008 for its up coming rights offering (the “Rights Offering”).
